Cargando…

High-Mobility Group Box-1 Protein Serum Levels Do Not Reflect Monocytic Function in Patients with Sepsis-Induced Immunosuppression

Background. High-mobility group box-1 (HMGB-1) protein is released during “late sepsis” by activated monocytes. We investigated whether systemic HMGB-1 levels are associated with indices of monocytic activation/function in patients with sepsis-induced immunosuppression. Methodology. 36 patients (31...

Descripción completa

Detalles Bibliográficos
Autores principales:	Unterwalder, Nadine, Meisel, Christian, Savvatis, Konstantinos, Hammoud, Ben, Fotopoulou, Christina, Volk, Hans-Dieter, Reinke, Petra, Schefold, Joerg C.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905954/ https://www.ncbi.nlm.nih.gov/pubmed/20652004 http://dx.doi.org/10.1155/2010/745724

Ejemplares similares

Postoperative Immunosuppression After Open and Laparoscopic Liver Resection: Assessment of Cellular Immune Function and Monocytic HLA-DR Expression
por: Chopra, Sascha S., et al.
Publicado: (2013)

Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis
por: Poehlmann, Holger, et al.
Publicado: (2009)

Immunoadsorption of lipopolysaccharides, IL-6 and complement-activation product 5a in severe sepsis and septic shock
por: Schefold, J, et al.
Publicado: (2006)

Immune biomarker-based enrichment in sepsis trials
por: Spinetti, Thibaud, et al.
Publicado: (2020)

Assessment of monocytic HLA-DR expression in ICU patients: analytical issues for multicentric flow cytometry studies
por: Monneret, Guillaume, et al.
Publicado: (2010)

Zoledronate rescues immunosuppressed monocytes in sepsis patients
por: Raffray, Loïc, et al.
Publicado: (2019)

Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome
por: Loebel, Madlen, et al.
Publicado: (2014)

Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients
por: Spinetti, Thibaud, et al.
Publicado: (2020)

To be, or not to be immunocompetent
por: Volk, Hans-Dieter, et al.
Publicado: (2013)

Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis
por: Otto, Carolin, et al.
Publicado: (2020)

Cardiac (myo)fibroblasts modulate the migration of monocyte subsets
por: Pappritz, Kathleen, et al.
Publicado: (2018)

Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock
por: Schefold, Joerg C
Publicado: (2011)

Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients
por: Amini, Leila, et al.
Publicado: (2019)

Flow Cytometric Analysis of Monocytes Polarization and Reprogramming From Inflammatory to Immunosuppressive Phase During Sepsis
por: Greco, Marilena, et al.
Publicado: (2019)

Association between thrombomodulin and high mobility group box 1 in sepsis patients
por: Rodrigues, Adriana Teixeira, et al.
Publicado: (2020)

Lactate and Immunosuppression in Sepsis
por: Nolt, Benjamin, et al.
Publicado: (2018)

Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes
por: Liu, Nianping, et al.
Publicado: (2021)

Early changes of the kinetics of monocyte trem-1 reflect final outcome in human sepsis
por: Marioli, Androniki, et al.
Publicado: (2014)

An in vitro model to assess the immunosuppressive effect of tick saliva on the mobilization of inflammatory monocyte-derived cells
por: Vachiery, Nathalie, et al.
Publicado: (2015)

BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
por: Liu, Wei, et al.
Publicado: (2022)

Predicting outcome in abdominal sepsis: putting the puzzle together
por: Reid, Catherine S., et al.
Publicado: (2021)

Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers
por: Pfortmueller, Carmen Andrea, et al.
Publicado: (2017)

Association of plasma level of high-mobility group box-1 with necroptosis and sepsis outcomes
por: Yoo, Hongseok, et al.
Publicado: (2021)

Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells With Therapeutic Prospects
por: Lei, Hong, et al.
Publicado: (2019)

Macrophage phenotype in sepsis immunosuppression
por: Theodorakis, E, et al.
Publicado: (2015)

Potential Immunotherapeutics for Immunosuppression in Sepsis
por: Shin, Jinwook, et al.
Publicado: (2017)

Sepsis-Induced Immunosuppression in Neonates
por: Hibbert, Julie E., et al.
Publicado: (2018)

Intensive care unit—acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock
por: Schefold, Joerg C., et al.
Publicado: (2010)

Inflammasomes: Pandora’s box for sepsis
por: Kumar, Vijay
Publicado: (2018)

Monocytes Undergo Functional Reprogramming to Generate Immunosuppression through HIF-1α Signaling Pathway in the Late Phase of Sepsis
por: Li, Li-Li, et al.
Publicado: (2020)

Single-cell transcriptome profiling of sepsis identifies HLA-DR(low)S100A(high) monocytes with immunosuppressive function
por: Yao, Ren-Qi, et al.
Publicado: (2023)

Antagonism of Cerebral High Mobility Group Box 1 Ameliorates Dendritic Cell Dysfunction in Sepsis
por: Ren, Chao, et al.
Publicado: (2021)

High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy
por: DeWulf, Bram, et al.
Publicado: (2023)

Regulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct manners
por: Lei, Hong, et al.
Publicado: (2015)

SIGLEC1 (CD169) is a sensitive biomarker for the deterioration of the clinical course in childhood systemic lupus erythematosus
por: von Stuckrad, Sae Lim, et al.
Publicado: (2020)

Advances in the Study of Immunosuppressive Mechanisms in Sepsis
por: Fu, Xuzhe, et al.
Publicado: (2023)

Mechanisms of sepsis‐induced immunosuppression and immunological modification therapies for sepsis
por: Ono, Satoshi, et al.
Publicado: (2018)

Role of high-mobility group box 1 in patients with acute obstructive suppurative cholangitis-induced sepsis
por: Singh, Akanand, et al.
Publicado: (2015)

Activation of Toll-Like Receptors 2 by High-Mobility Group Box 1 in Monocytes from Patients with Ischemic Stroke
por: Sadat-Hatamnezhad, Leila, et al.
Publicado: (2016)

MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy
por: Moll, Guido, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5bk6bcaq657fqerkhvrlokpq2m